ArcaMax

High blood pressure (HBP) causes more than 664,000 deaths in the U.S. annually, despite the fact that we know how to prevent and treat the condition with lifestyle choices and medicines.

Unfortunately, not many folks get enough pressure-lowering exercise or eat a healthy plant-based diet -- and antihypertensive medicines aren't universally well-received. One study found that 41% of folks stopped taking their HBP medicines because of perceived side effects.

So, researchers decided to figure out which antihypertensives folks are most likely to stick with. Their review in JAMA Network Open found that folks were most likely to discontinue taking calcium channel blockers and combos of beta-blockers and ACE inhibitors and of beta-blockers plus thiazide diuretics. However, regimens containing ARBs (angiotensin II receptor blockers) were more likely to be continued. I like telmisartan (Micardis) and valsartan (Diovan). (The latter's side effect is an increase in libido.)

Now, your case of high blood pressure (along with other chronic conditions) may call for an antihypertensive therapy that's less tolerable. If you've stopped taking your meds (I bet you haven't told your doc), discuss what you might stick with that targets your special health needs.

Also, increase your bean and soy consumption. One study found that you'll achieve a 30% reduction in your risk for HBP if you eat around 6 ounces of beans daily and a 28% reduction if you eat 2-3 ounces of soy a day. (Eating them frequently -- but not daily -- also provides impressive benefits.) For more info on preventing and treating HBP, check out my book, "The Great Age Reboot."

Health pioneer Michael Roizen, M.D., is chief wellness officer emeritus at the Cleveland Clinic and author of four No. 1 New York Times bestsellers. Check out his latest, "The Great Age Reboot: Cracking the Longevity Code for a Younger Tomorrow," and find out more at www.4YOUngevity.com. Email your health and wellness questions to Dr. Mike at questions@4YOUngevity.com.

(c)2026 Michael Roizen, M.D.

Distributed by King Features Syndicate, Inc.

(c) 2026 Michael Roizen, M.D. Distributed by King Features Syndicate, Inc.